
Ian Antheni Myles MD MPH, LCDR
Clinical & Laboratory Immunology
Head, Epithelial Therapeutics Unit/Chief Medical Officer
Join to View Full Profile
9000 Rockville PikeBLD 29b Room 5NN24Bethesda, MD 20892
Dr. Myles is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 2008 - 2010
- Ohio State University HospitalResidency, Internal Medicine, 2005 - 2008
- University of Colorado School of Medicine Anschutz Medical CampusClass of 2005
Certifications & Licensure
- OH State Medical License 2007 - 2026
- American Board of Allergy and Immunology Allergy & Immunology
Publications & Presentations
PubMed
- Topical Steroid Withdrawal Is a Targetable Excess of Mitochondrial NAD.Nadia Shobnam, Grace Ratley, Sarini Saksena, Manoj Yadav, Prem Prashant Chaudhary
The Journal of Investigative Dermatology. 2025-02-10 - 1 citationsSalt and Atopic Dermatitis.Ian A Myles, Jeffrey B Kopp
JAMA Dermatology. 2025-02-01 - Environmental and behavioral mitigation strategies for patients with atopic dermatitis.Nadia Shobnam, Grace Ratley, Jordan Zeldin, Manoj Yadav, Ian A Myles
JAAD International. 2024-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: